MedTrace Logo

Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.

NCT06208137 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 456

Last updated 2024-08-13

No results posted yet for this study

Summary

To assess the effectiveness of interventions including health monitoring and regular return follow-up reminders for patients with a high Composite Immune Risk Score.

Conditions

  • Transplant-Related Disorder

Interventions

BEHAVIORAL

Health monitoring and regular return follow-up reminders

Health monitoring \& reminders for blood tests and follow-up visits until 1 year post-transplant

Sponsors & Collaborators

  • Institute of Hematology & Blood Diseases Hospital, China

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-29
Primary Completion
2027-10-01
Completion
2028-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06208137 on ClinicalTrials.gov